Politics

Senator Named to Massachusetts Regulatory Post Opposed Legal Cannabis

Published on August 23, 2017 · Last updated July 28, 2020

BOSTON (AP) — A Democratic state senator who opposed the ballot question that legalized recreational marijuana was named Wednesday by Republican Gov. Charlie Baker to the regulatory board that will oversee the cannabis industry in Massachusetts.

Sen. Jennifer Flanagan, of Leominster, is the first appointee to the five-member Cannabis Control Commission. She will serve as an associate commissioner beginning on Sept. 1 after resigning from her Senate seat at the end of the month.

The governor, in a statement, touted Flanagan’s experience in the Legislature on issues involving substance abuse prevention, treatment and recovery as invaluable to the state’s goal of “effective, responsible and safe implementation of the adult use of marijuana.”

Flanagan played a key role in crafting a 2016 state law that offered several new approaches to stemming the deadly opioid addiction crisis. She opposed the marijuana initiative on the November ballot, citing concerns over unknown or unanswered questions about what legalization might mean to Massachusetts.

Baker also opposed the ballot question, which passed with the support of about 1.8 residents, or 56 percent of statewide voters.

Flanagan is expected to receive an annual salary of about $120,000.

A bill signed earlier this month that made revisions to the voter-approved law gave Baker, Democratic state Treasurer Deb Goldberg and Democratic Attorney General Maura Healey each a hand in appointing the Cannabis Control Commission. Goldberg is tasked with naming the person who will chair the panel. The governor’s appointee was required to have a background in public health, mental health or substance abuse.

The commission will oversee both recreational and medical marijuana. It’s charged with screening and licensing applicants for retail cannabis shops that are expected to begin opening in mid-2018.

“I look forward to serving on the commission as Massachusetts moves forward in responsibly regulating this new industry,” Flanagan said in a brief statement.

An aide said the senator planned no further comments on Wednesday.

Jim Borghesani, a spokesman for the group that led the drive to legalize recreational cannabis, said he hoped Flanagan “would put her personal position aside to advance the will of Massachusetts voters.”

He noted that Baker earlier tapped Walpole Police Chief John Charmichael Jr., an outspoken opponent of marijuana legalization, for an advisory board that will make recommendations to the regulatory commission.

As an associate commissioner, Flanagan is expected to receive an annual salary of about $120,000. She earned $84,233 as a state lawmaker in 2016, according to the state’s Open Checkbook website.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries

Flanagan, considered a moderate Democrat, was elected to the state House of Representatives in 2004 and to the Senate four years later.

Massachusetts is one of eight states where voters have legalized adult recreational marijuana use.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
The Associated Press
The Associated Press
The AP is one of the world's largest and most trusted sources of independent newsgathering.
View The Associated Press's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.